Study in Patients With COPD

Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol

NCT01555099 ·Status: COMPLETED ·Phase: PHASE2

A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease

NCT01113593 ·Status: COMPLETED ·Phase: PHASE2

Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease

NCT03414541 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT01437540 ·Status: COMPLETED ·Phase: PHASE3

Enhancement of in-Vitro GC Function in Patients With COPD

NCT00241631 ·Status: COMPLETED ·Phase: PHASE2

A Crossover Study in the Treatment of Patients With COPD

NCT00462540 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD

NCT00064415 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00782535 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations

NCT00116402 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01013142 ·Status: COMPLETED ·Phase: PHASE1

A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00685841 ·Status: COMPLETED ·Phase: PHASE3

A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease

NCT01009424 ·Status: WITHDRAWN ·Phase: PHASE1

A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease

NCT00774761 ·Status: COMPLETED ·Phase: PHASE2

Budesonide / Formoterol in Treatment of Exacerbations of COPD

NCT00239278 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT01009463 ·Status: COMPLETED ·Phase: PHASE3

Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)

NCT00742248 ·Status: COMPLETED ·Phase: PHASE2

Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD

NCT00064402 ·Status: COMPLETED ·Phase: PHASE3

Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01154127 ·Status: COMPLETED ·Phase: PHASE3

NVA237 BID Versus Placebo Twelve-week Efficacy Study

NCT01715298 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Characteristics of Roflumilast in COPD Patients

NCT02671942 ·Status: TERMINATED ·Phase: PHASE2

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00671073 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

NCT01049360 ·Status: COMPLETED ·Phase: PHASE2

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

NCT00403286 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)

NCT01488019 ·Status: COMPLETED ·Phase: PHASE4

Enhancement of Corticosteroid Efficacy in COPD

NCT02340520 ·Status: COMPLETED ·Phase: PHASE3